biopharmaceuticals
Expansion gives biopharma companies fast access to synthetic CRISPR sgRNA and non-viral DNA payloads
| 2 min read
Recombinant antibody production uses genetic engineering to create antibodies in labs, avoiding animal immunization. Antibody genes are cloned into expression vectors, inserted into host cells, and purified for various applications.
| 4 min read
µPAC Neo HPLC Columns deliver improved separation performance and stability for biologically complex samples
| 1 min read
Grow large quantities of adherent cells in a compact space with a substantial increase in cell growth surface compared to traditional vessels of comparable cubic footprint
| 1 min read
New digital PCR research solution the Applied Biosystems™ QuantStudio™ Absolute Q™ AutoRun dPCR Suite
| 1 min read
Engineers find specialized nanoparticles can quickly and inexpensively isolate proteins from a bioreactor
| 4 min read
Most industry spending is not on research and development
| 2 min read
Automating and simplifying the process development of biopharmaceuticals brings us closer to more personalized medicine
| 2 min read
Future cancer drugs may one day be formulated from glycoalkaloids found in plants from the genus Solanum
| 3 min read
Recognizing that plastics are still crucial for biopharmaceutical development, labs can take a circular approach to product design and explore advanced recycling methods to improve industry sustainability
| 3 min read
